Announcements Trials
Browse Landscape

Phase

Phase 2 69Phase 1 34Phase 1/2 17Phase EARLY_PHASE1 6Phase 3 5Phase NA 1

Status

Recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

NIH 25OTHER 5NETWORK 3

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Gynecologic 1Genitourinary 1

Conditions

Stroke 1Pulmonary Disease, Chronic Obstructive 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Kidney Failure, Chronic 1Diabetes Mellitus 1Coronary Artery Disease 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1COVID-19 1Appendiceal Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Disulfides × Clear all
NCT05624996 2026-05-04

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

NRG Oncology

Phase 3 Recruiting
474 enrolled
Thoracic

Lung Neoplasms

NCT07166406 2026-05-04

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

NRG Oncology

Phase 3 Recruiting
226 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06580314 2026-03-24

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

NRG Oncology

Phase 3 Recruiting
880 enrolled
Gynecologic

Ovarian Neoplasms

NCT07271355 2025-12-09

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

City of Hope Medical Center

Phase 3 Not yet recruiting
129 enrolled
Gastrointestinal

Appendiceal Neoplasms, Colorectal Neoplasms

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

Phase 3 Withdrawn
Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡